196 related articles for article (PubMed ID: 36412281)
1. Quxie Capsule Alleviates Colitis-associated Colorectal Cancer Through Modulating the Gut Microbiota and Suppressing
Zhang Z; Chen Y; Zheng Y; Wang L; Shen S; Yang G; Yang Y; Wang T
Integr Cancer Ther; 2022; 21():15347354221138534. PubMed ID: 36412281
[TBL] [Abstract][Full Text] [Related]
2. Quxie Capsule Modulating Gut Microbiome and Its Association With T cell Regulation in Patients With Metastatic Colorectal Cancer: Result From a Randomized Controlled Clinical Trial.
Sun L; Yan Y; Chen D; Yang Y
Integr Cancer Ther; 2020; 19():1534735420969820. PubMed ID: 33243018
[TBL] [Abstract][Full Text] [Related]
3. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota.
Zhu W; Li J; Chen Y; Liu Z; Zhang Q; Kang C
Int Immunopharmacol; 2023 Mar; 116():109768. PubMed ID: 36731153
[TBL] [Abstract][Full Text] [Related]
4. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
[TBL] [Abstract][Full Text] [Related]
5. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.
Wu M; Wu Y; Deng B; Li J; Cao H; Qu Y; Qian X; Zhong G
Oncotarget; 2016 Dec; 7(51):85318-85331. PubMed ID: 27863401
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects on colitis-associated tumorigenesis and gut microbiota in mice between Ophiocordyceps sinensis and Cordyceps militaris.
Ji Y; Tao T; Zhang J; Su A; Zhao L; Chen H; Hu Q
Phytomedicine; 2021 Sep; 90():153653. PubMed ID: 34330600
[TBL] [Abstract][Full Text] [Related]
8. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.
Liu M; Xie W; Wan X; Deng T
Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of Pai-Nong-San against AOM/DSS-induced CAC in mice through inhibiting the Wnt signaling pathway.
Zhang MM; Yin DK; Rui XL; Shao FP; Li JC; Xu L; Yang Y
Chin J Nat Med; 2021 Dec; 19(12):912-920. PubMed ID: 34961589
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
11. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
12. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis.
Hidalgo-García L; Ruiz-Malagon AJ; Huertas F; Rodríguez-Sojo MJ; Molina-Tijeras JA; Diez-Echave P; Becerra P; Mirón B; Morón R; Rodríguez-Nogales A; Gálvez J; Rodríguez-Cabezas ME; Anderson P
Pharmacol Res; 2023 Sep; 195():106891. PubMed ID: 37586618
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism.
Wang L; Wang R; Wei GY; Zhang RP; Zhu Y; Wang Z; Wang SM; Du GH
Pharmacol Res; 2021 Jan; 163():105232. PubMed ID: 33027716
[TBL] [Abstract][Full Text] [Related]
14. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
[TBL] [Abstract][Full Text] [Related]
15. Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells.
Yun X; Zhang Q; Fang Y; Lv C; Chen Q; Chu Y; Zhu Y; Wei Z; Xia Y; Dai Y
Biochem Pharmacol; 2022 Aug; 202():115138. PubMed ID: 35700756
[TBL] [Abstract][Full Text] [Related]
16. Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis.
Xie B; Wang B; Shang R; Wang L; Huang X; Xie L
Sci Rep; 2023 Dec; 13(1):22552. PubMed ID: 38110638
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
Shi G; Kong J; Wang Y; Xuan Z; Xu F
J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice.
Chang ZY; Liu HM; Leu YL; Hsu CH; Lee TY
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269806
[TBL] [Abstract][Full Text] [Related]
19. Quxie Capsule Inhibits Colon Tumor Growth Partially Through Foxo1-Mediated Apoptosis and Immune Modulation.
Chen D; Yang Y; Yang P
Integr Cancer Ther; 2019; 18():1534735419846377. PubMed ID: 31030593
[TBL] [Abstract][Full Text] [Related]
20. Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB/IL6-STAT3 signaling pathway.
Jiang F; Liu M; Wang H; Shi G; Chen B; Chen T; Yuan X; Zhu P; Zhou J; Wang Q; Chen Y
Biomed Pharmacother; 2020 May; 125():109982. PubMed ID: 32119646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
